$KEY

Ramani Mohit sold $568K of KEY

Ramani Mohit (Chief Risk Officer) sold 25,000 shares of KEYCORP /NEW/ (KEY) at $22.74 ($0.57M total) on 2026-07-22.

Original reporting
SEC EDGAR · Ramani Mohit
Published Jul 24, 2026, 8:06 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 24, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$KEY
Neutral
medium confidence
Mentioned
$KEY
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KEYNeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price, and post-transaction holdings. It may marginally influence sentiment but does not introduce new fundamentals.

02

Market read

Traders may monitor for follow-on insider activity, but this single sale alone is unlikely to drive a sustained repricing.

03

What to watch

The filing does not state a 10b5-1 plan, but it also does not provide context for why the sale occurred, limiting inference about future risk or earnings.

Relevance 5/10Novelty 4/10Timing: Filed 2026-07-24 after-hours; reflects sale executed 2026-07-22.

Background

This is an SEC Form 4 insider transaction disclosure for KEYCORP, reported by Chief Risk Officer Ramani Mohit.

Company-level read

Ticker impact

$KEYNeutralMedium confidence
Context

SEC Form 4 shows KEYCORP Chief Risk Officer Ramani Mohit sold 25,000 shares at $22.74 on 2026-07-22, totaling $568,500.

Expected impact

Likely limited near-term impact; any effect should be small and sentiment-driven rather than trend-changing.

Evidence & confidence

The filing is a primary-source insider transaction, but it provides no new company-specific operating, regulatory, or financial datapoint. Insider sales can be planned or tax-related; absence of a stated 10b5-1 plan adds some uncertainty but still lacks evidence of business deterioration.

Market effects

Minimal. One insider sale does not materially change bank-sector fundamentals or risk outlook.

None indicated.

None indicated.

Counterpoint

The sale could be non-informational (tax, diversification, or personal liquidity), so price reaction may be overstated.

Key entities

  • KEYCORP /NEW/

    Subject of the Form 4 insider transaction disclosure.

  • Ramani Mohit

    Chief Risk Officer who sold 25,000 shares.

Related articles

$KEYMedAI 8/10

FCA clears acquisition of Clearwater UK by KeyCorp

The UK Financial Conduct Authority cleared KeyCorp’s acquisition of corporate finance advisory firm Clearwater UK. KeyCorp completed the deal on 4 August 2026 and notified investors on the New York Stock Exchange. The article says Clearwater UK will use KeyCorp’s expertise for corporate finance advisory services.

$KEYMed

KeyCorp Q2 2026 Earnings Call Summary

KeyCorp’s Q2 2026 earnings call cited 3% sequential commercial loan growth, net interest margin expansion to 2.89%, and 12% growth in commercial payments fees. Management raised full-year revenue guidance to 7-8% growth and projected NIM of 3.0% to 3.05% by year-end, plus $1.3B+ in 2026 buybacks.

$AUBMed

Banks face a dilemma: More loan growth or better margins?

The article says banks face a tradeoff between loan growth and net interest margin (NIM). Atlantic Union Bankshares grew loans by $727M in Q2 and adjusted 2026 NIM guidance to 3.9% to 3.95% from 3.9% to 4.0%, citing higher deposit costs. It also notes KeyCorp and M&T Bank expect some NIM compression to fund loan growth.

$KEYMedAI 8/10

KEYCORP REPORTS SECOND QUARTER 2026 NET INCOME OF $472 MILLION, OR $0.44 PER DILUTED COMMON SHARE INCREASING 26% YEAR-OVER-YEAR

KeyCorp (NYSE: KEY) reported Q2 2026 net income from continuing operations attributable to common shareholders of $472 million, or $0.44 per diluted share, up 26% YoY. Revenue rose 7% to $1.96 billion. Net interest income increased 9% YoY; net interest margin was 2.89%. Period-end loans rose $1.2 billion sequentially and Key repurchased $341 million of shares.

$KEYMed

KEYCORP /NEW/ (KEY): Results of Operations and Financial Condition

KEYCORP /NEW/ (KEY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a2q26earningsrelease.htm EX-99.1 Document KEYCORP REPORTS SECOND QUARTER 2026 NET INCOME OF $472 MILLION, OR $0.44 PER DILUTED COMMON SHARE INCREASING 26% YEAR-OVER-YEAR Revenue of $1.96 billion, up 7% year-over-year Net interest income up 9% year-over-year and 2% seque

$KEYLow

Why Chasing High Yields Is the Fastest Way to Lose Money

The article warns that chasing very high dividend yields can expose investors to companies with weak earnings, high debt, or unsustainable payouts. It highlights Canadian stocks Keyera (KEY) and Manulife Financial (MFC) as lower-risk alternatives. Keyera trades near $55, yields ~4%, and reported Q1 adjusted EBITDA of $203m ($232m excluding Plains deal costs) with net debt/adj. EBITDA of 2.2x. Manulife trades near $51, yields 3.5%, and in its latest quarter core earnings rose 8% YoY to $1.8b and